TremblayGSeemayerTAMassonPierre (1880–1959). Un grand maitre de l'histopathologie des tumeurs. Le Bull du Cancer2000;87:625–629.
6.
SeemayerTA. Founders of pediatric pathology: Frederick W. Wiglesworth. Perspect Pediatr Pathol1987;10:1–6.
7.
BolandeRP. The neurocristopathies: a unifying concept of human disease arising in neural crest maldevelopment. Hum Pathol1974;5:409–429.
8.
LagercrantzHSlotkinTA. The “stress” of being born. Sci Amer1986;254:100–107.
9.
BolandeRP. Neurocristopathy: its growth and development in 20 years. Pediatr Pathol Lab Med1997;17:1–26.
10.
SeemayerTA. Founders of pediatric pathology: Robert P. Bolande. Perspect Pediatr Pathol2000;22:6–10.
11.
NezelofCSeemayerTABridgeJA. Contributions of pediatrics and pediatric pathology to the body of medical knowledge. Hum Pathol2010;41:309–315.
12.
SeemayerTA. Founders of pediatric pathology: Christian Nezelof. Perspect Pediatr Pathol2001;23:11–15.
13.
SeemayerTABolandeRP. Thymic involution mimicking thymic dysplasia, a consequence of transfusion-induced graft-versus-host disease in a premature infant. Arch Pathol Lab Med1980;104:141–144.
14.
DesbaratsJSeemayerTALappWS. Irradiation of the skin and systemic graft-versus-host disease synergize to produce cutaneous lesions. Am J Pathol1994;144:883–888.
15.
NestelFKichianKYou-TenK. The role of endotoxin in the pathogenesis of acute graft-versus-host disease. In: FerraraJLMDeegJHBurakoffSJ, eds. Graft-vs-Host Disease, 2nd ed.New York: Marcel Dekker, 1997;501–523.
16.
SeemayerTATannenbaumGSGoldmanHColleE. Dynamic time-course studies of the spontaneous diabetic BB Wistar rat. III. Light microscopic and ultrastructural observations of pancreatic islets of Langerhans. Am J Pathol1982;106:237–249.
17.
Issa-CherguiBGoldner-SauvéAColleE. Class I and II major histocompatibility complex gene product expression by a rat insulinoma cell line in vitro following exposure to gamma interferon. Diabetologia1988;31:675–680.
18.
SeemayerTASchürchWLagacéRTremblayG. Myofibroblasts in the stroma of invasive and metastatic carcinoma: a possible host response to neoplasia. Am J Surg Pathol1979;3:525–533.
19.
SchürchWSeemayerTAHinzBGabbianiG. Myofibroblast. In: MillsSE, ed. Histology for Pathologists, 3rd ed.Philadelphia: Lippincott, Williams & Wilkins, 2007;123–164.
20.
SeemayerTAGrossTGEgelerRM. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res1995;38:471–478.
21.
GrossTGFilipovitchAHConleyME. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic stem cell transplantation: report from the XLP Registry. Bone Marrow Transplant1996;17:741–744.
22.
SumegiJHuangDLanyiA. Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood2000;96:3118–3125.
23.
SeemayerTAGrossTGLanyiASumegiJ. X-linked lymphoproliferative disease. In: TselisAJensonHB, eds. Epstein-Barr Virus. New York: Taylor & Francis, 2006;311–333.
SeemayerTANezelofC. The thymus, lymph nodes, spleen and primary immunodeficiency disorders. In: Gilbert-BarnessE, ed. Potter's Pathology of the Fetus, Infant and Child, 2nd ed.Edinburgh: Elsevier, 2007;1537–1577.
27.
NezelofCSeemayerTA. Robert Alan Good ou les intuitions géniales d'un immunologiste. Revue du practicien2004;54:1153–1157.
28.
TotiPDe FeliceCStumpoM. Acute thymic involution in fetuses and neonates with chorioamnionitis. Hum Pathol2000;31:1121–1128.